Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study, Haematologica, vol.98, issue.2, pp.230-238, 2013. ,
DOI : 10.3324/haematol.2012.064014
Estimation nationale de l'incidence des cancers en France entre, 1980. ,
New strategies for relapsed acute myeloid leukemia, Current Opinion in Hematology, vol.21, issue.2, pp.79-86, 2014. ,
DOI : 10.1097/MOH.0000000000000018
Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation, Journal of Clinical Oncology, vol.19, issue.16, pp.3675-84, 2001. ,
DOI : 10.1200/JCO.2001.19.16.3675
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel, Blood, vol.129, issue.4, pp.424-471, 2017. ,
DOI : 10.1182/blood-2016-08-733196
One million haemopoietic stem-cell transplants: a retrospective observational study, The Lancet Haematology, vol.2, issue.3, pp.91-100 ,
DOI : 10.1016/S2352-3026(15)00028-9
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia, Cancer, vol.46, issue.Suppl. 1, pp.4238-4284, 1997. ,
DOI : 10.1038/bmt.2010.69
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Espa??ol de Trasplante Hematopoyetico, Biology of Blood and Marrow Transplantation, vol.22, issue.3, pp.584-592, 2016. ,
DOI : 10.1016/j.bbmt.2015.11.012
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes, Bone Marrow Transplantation, vol.9, issue.2, 2016. ,
DOI : 10.1038/sj.bmt.1705011
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation, Bone Marrow Transplantation, vol.12, issue.11, pp.1027-1059, 2007. ,
DOI : 10.1016/S0301-472X(03)00225-X
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.16, issue.11, pp.1467-503, 2010. ,
DOI : 10.1016/j.bbmt.2010.08.001
When is second allogeneic HSCT for relapse of acute leukaemia an option? Bone Marrow Transplantation, Feb, vol.51, issue.2, pp.184-189, 2016. ,
ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?, Hematology, vol.2009, issue.1, pp.414-422, 2009. ,
DOI : 10.1182/asheducation-2009.1.414
Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ???10 years, Bone Marrow Transplantation, vol.86, issue.12, pp.1508-1520, 2015. ,
DOI : 10.1016/j.bbmt.2011.11.017
Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy, Bone Marrow Transplantation, vol.19, issue.7, pp.709-728, 1997. ,
DOI : 10.1038/sj.bmt.1700720
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant, Bone Marrow Transplantation, vol.34, issue.8, 2004. ,
DOI : 10.1038/sj.bmt.1704645
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT, Bone Marrow Transplantation, vol.19, issue.12, pp.1542-50, 2015. ,
DOI : 10.1038/sj.bmt.1704761
Management of relapse after allo-SCT for AML and the role of second transplantation, Bone Marrow Transplantation, vol.26, issue.12, pp.769-77, 2009. ,
DOI : 10.4049/jimmunol.169.8.4253
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant, Bone Marrow Transplantation, vol.74, issue.12, pp.783-792, 2008. ,
DOI : 10.1111/j.1423-0410.1998.tb05438.x
The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?, Transfusion and Apheresis Science, vol.54, issue.1, pp.91-99, 2016. ,
DOI : 10.1016/j.transci.2016.01.020
Risk score for outcome after allogeneic hematopoietic stem cell transplantation, Cancer, vol.25, issue.20, pp.4715-4741, 1920. ,
DOI : 10.1002/cncr.24531
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT, Blood, vol.106, issue.8, pp.2912-2921, 2005. ,
DOI : 10.1182/blood-2005-05-2004
EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure, Biology of Blood and Marrow Transplantation, vol.18, issue.2, pp.235-275, 2012. ,
DOI : 10.1016/j.bbmt.2011.06.010
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens., Journal of Clinical Oncology, vol.11, issue.2, pp.304-317, 1993. ,
DOI : 10.1200/JCO.1993.11.2.304
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation, The Lancet, vol.352, issue.9134, pp.1087-92, 1998. ,
DOI : 10.1016/S0140-6736(98)03030-X
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia, Bone Marrow Transplantation, vol.18, issue.2, pp.157-62, 2005. ,
DOI : 10.1038/sj.bmt.1701146
Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from the SFGM-TC, Biology of Blood and Marrow Transplantation, vol.18, issue.2, pp.250-256, 2012. ,
DOI : 10.1016/j.bbmt.2011.06.015
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplantation, Feb, vol.52, issue.2, pp.191-197, 2017. ,
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation, Leukemia, vol.26, issue.6, pp.1229-1264, 2013. ,
DOI : 10.1200/JCO.2008.16.0259
Crucial Role of DNA Methylation in Determination of Clonally Distributed Killer Cell Ig-like Receptor Expression Patterns in NK Cells, The Journal of Immunology, vol.169, issue.8, pp.4253-61, 2002. ,
DOI : 10.4049/jimmunol.169.8.4253
Midostaurin, a multi-targeted kinase inhibitor, improves overall survival when added to standard chemotherapy in adults age 18 ? 60 with FLT3 mutant acute myeloid leukemia (AML): results from a randomized, prospective, placebo-controlled, double-blind trial, CALGB 10603, 2015. ,
Ipilimumab for Patients with Relapse after Allogeneic Transplantation, New England Journal of Medicine, vol.375, issue.2, pp.143-53, 2016. ,
DOI : 10.1056/NEJMoa1601202
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation, Bone Marrow Transplantation, vol.52, issue.2, 2017. ,
DOI : 10.1016/j.ejca.2015.11.016
Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML, Bone Marrow Transplantation, vol.25, issue.7, pp.901-908 ,
DOI : 10.1016/j.bbmt.2011.07.012
Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survival, Bone Marrow Transplantation, vol.48, issue.9, pp.1192-1199, 2013. ,
DOI : 10.1182/blood-2009-10-248997
Second HLA-identical sibling transplants for leukemia recurrence, Bone Marrow Transplant, vol.9, issue.4, pp.269-75, 1992. ,
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM), British Journal of Haematology, vol.300, issue.2 ,
DOI : 10.1038/bjc.1977.1
Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long-term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON) Haematologica, 2002. ,
Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTY, British Journal of Haematology, vol.7, issue.4, pp.567-74, 1991. ,
DOI : 10.1038/bjc.1977.1
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study, Bone Marrow Transplantation, vol.27, issue.12, pp.1221-1226, 2001. ,
DOI : 10.1038/sj.bmt.1703028
Second allogeneic transplants for leukemia using blood instead of bone marrow as a source of hemopoietic cells, Bone Marrow Transplant, 1996. ,
Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change, Journal of Clinical Oncology, vol.31, issue.26, pp.313259-71, 2013. ,
DOI : 10.1200/JCO.2012.44.7961
Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study, Biology of Blood and Marrow Transplantation, vol.21, issue.3, pp.454-463, 2015. ,
DOI : 10.1016/j.bbmt.2014.11.007
Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes, Bone Marrow Transplantation, vol.19, issue.5, pp.461-467, 1997. ,
DOI : 10.1038/sj.bmt.1700680
Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies After Allogeneic Stem-Cell Transplantation, Journal of Clinical Oncology, vol.20, issue.2, pp.405-417, 2002. ,
DOI : 10.1200/JCO.2002.20.2.405
Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts, Biology of Blood and Marrow Transplantation, vol.20, issue.10, pp.1573-1582, 2014. ,
DOI : 10.1016/j.bbmt.2014.05.029
Conditionnements avant allogreffe, Hematologie, vol.19, pp.11-14, 2013. ,
Second haploidentical peripheral blood stem cell transplantation for treatment of acute leukemia with relapse after first allogeneic peripheral blood stem cell transplantation, Bone Marrow Transplantation, vol.18, issue.7, pp.1001-1004 ,
DOI : 10.1016/j.bbmt.2012.06.019
Second hematopoietic stem cell transplantation in myeloid malignancies, Current Opinion in Hematology, vol.16, issue.2, pp.112-135, 2009. ,
DOI : 10.1097/MOH.0b013e3283257a87
Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change, Journal of Clinical Oncology, vol.31, issue.26, pp.313259-71, 2013. ,
DOI : 10.1200/JCO.2012.44.7961
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes, Bone Marrow Transplantation, vol.9, issue.2, pp.186-93, 2016. ,
DOI : 10.1038/sj.bmt.1705011